Læknablaðið

Årgang

Læknablaðið - 15.06.1999, Side 61

Læknablaðið - 15.06.1999, Side 61
LÆKNABLAÐIÐ 1999; 85 553 patients are prone to withhold information. This is also apt to have serious consequences (see Breach of patient/physi- cian trust below). 2) Breach of patient/phy- sician trust Physicians will be forced to hand over entrusted informa- tion. The transfer of medical records to third parties will undermine the confidence between patients and physi- cians and have at least two serious consequences. First, patients worried about the pri- vacy of sensitive medical in- formation may withhold in- formation from the physician, increasing the risk of tnisdia- gnosis and inadequate or inap- propriate treatment. Second, if there is erosion of trust the information is likely to be- come unreliable and scientific conclusions reached from such data will consequently be of inferior quality. Not only are physicians forced to hand over informa- tion to third parties but physi- cians in public institutions will have no veto power re- garding the transfer of infor- mation into the database. Politically appointed boards of directors will be em- powered to negotiate all trans- fers of information, without any review by independent ethics committees. 3) The necessity of inde- pendent review mechanisms The Act has changed and weakened the role of the Ice- landic National Bioethics Committee formed according to the Act on Patients' Rights. The role of the National Bioethics Committee has been reduced from being an independent scrutinizer of all research protocols to one of accepting lists of queries and querors to the proposed Health Sector Database. According to rules set by the Ministry (Art. 12) the Act calls for a special interdisci- plinary ethics review commit- tee to replace functions pre- viously performed by the National Bioethics Commit- tee. Composed of representa- tives appointed by the Minis- try of Health, members of parliament have indicated that representatives of the licensee will sit in this committee to protect its interest. 4) Abuse of patient con- sent The HSD "presumes" that the data is not personally identifiable. The Act proposes to protect individual privacy by a one-way coding function - coding that can not be traced using a decoding key. This logic is used to circumvent the necessity of obtaining infor- med consent of the individual. In order to be able to update the database all institutions must, however, use the same coding function and the same function must also be used for the entire life of the database. Therefore, a key exists: the function itself is a key. By feeding the National Registry (which contains the names and personal identifying num- bers of 275.000 Icelanders) through the one-way function, a look-up table of names and pseudonyms can be formed. Hence, any person can be identified. This violates the guidelines of the European Data Protec- tion Act, set by the European Parliament and Council, which explicitly state that in- formed consent for participa- tion of human subjects in gathering and storing infor- mation is mandatory, as well as being an essential precon- dition to processing the data. All individuals (alive, de- ceased, unborn) will be inclu- ded in the database unless they opt out before June 17th, 1999. If individuals opt out after this date they are only able to stop the transfer of future data, previously en- tered data cannot be erased and thus these individuals may be subjects of research against their expressed ins- tructions. Relatives of the de- ceased have no say in protec- ting the rights of their de- ceased family members and all information on them wil! be included. 5) Disregarding of estab- lished scientific standards According to Article 6 access of scientists working at collaborating health institu- tions is negotiable but not legally binding. Access by scientists outside these insti- tutions is only possible if the scientist collaborates with the institution or negotiates di- rectly with the licensee. Thus the licensee gets to "pick and choose" who will get access to the database. The Icelandic Medical As- sociation strongly believes that monopolizing informa- tion and access to research subjects is not only harmful to scientific progress but also encroaches on the freedom of research. 6) Medical records as a commodity. The Act gives a single com- pany, the licensee, an exclu-
Side 1
Side 2
Side 3
Side 4
Side 5
Side 6
Side 7
Side 8
Side 9
Side 10
Side 11
Side 12
Side 13
Side 14
Side 15
Side 16
Side 17
Side 18
Side 19
Side 20
Side 21
Side 22
Side 23
Side 24
Side 25
Side 26
Side 27
Side 28
Side 29
Side 30
Side 31
Side 32
Side 33
Side 34
Side 35
Side 36
Side 37
Side 38
Side 39
Side 40
Side 41
Side 42
Side 43
Side 44
Side 45
Side 46
Side 47
Side 48
Side 49
Side 50
Side 51
Side 52
Side 53
Side 54
Side 55
Side 56
Side 57
Side 58
Side 59
Side 60
Side 61
Side 62
Side 63
Side 64
Side 65
Side 66
Side 67
Side 68
Side 69
Side 70
Side 71
Side 72
Side 73
Side 74
Side 75
Side 76
Side 77
Side 78
Side 79
Side 80
Side 81
Side 82
Side 83
Side 84
Side 85
Side 86
Side 87
Side 88
Side 89
Side 90
Side 91
Side 92
Side 93
Side 94
Side 95
Side 96
Side 97
Side 98
Side 99
Side 100
Side 101
Side 102
Side 103
Side 104

x

Læknablaðið

Direkte link

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.